Detalhe da pesquisa
1.
Time Trends in Causes of Death in People with HIV: Insights from the Swiss HIV Cohort Study.
Clin Infect Dis
; 2024 Jan 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-38214897
2.
Using longitudinally sampled viral nucleotide sequences to characterize the drivers of HIV-1 transmission.
HIV Med
; 22(5): 346-359, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33368946
3.
Chemsex drugs on the rise: a longitudinal analysis of the Swiss HIV Cohort Study from 2007 to 2017.
HIV Med
; 21(4): 228-239, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-31849182
4.
Treatment outcomes of integrase inhibitors, boosted protease inhibitors and nonnucleoside reverse transcriptase inhibitors in antiretroviral-naïve persons starting treatment.
HIV Med
; 21(9): 599-606, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32588958
5.
Quantifying the drivers of HIV transmission and prevention in men who have sex with men: a population model-based analysis in Switzerland.
HIV Med
; 19(10): 688-697, 2018 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30051600
6.
On the potential of a short-term intensive intervention to interrupt HCV transmission in HIV-positive men who have sex with men: A mathematical modelling study.
J Viral Hepat
; 25(1): 10-18, 2018 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28685917
7.
Mining for pairs: shared clinic visit dates identify steady HIV-positive partnerships.
HIV Med
; 18(9): 667-676, 2017 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-28378387
8.
HIV-1 Transmission During Recent Infection and During Treatment Interruptions as Major Drivers of New Infections in the Swiss HIV Cohort Study.
Clin Infect Dis
; 62(1): 115-122, 2016 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-26387084
9.
Protease inhibitors to treat hepatitis C in the Swiss HIV Cohort Study: high efficacy but low treatment uptake.
HIV Med
; 16(10): 599-607, 2015 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-26135140
10.
Efficacy of etravirine combined with darunavir or other ritonavir-boosted protease inhibitors in HIV-1-infected patients: an observational study using pooled European cohort data.
HIV Med
; 16(5): 297-306, 2015 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-25585664
11.
Expansion of interferon-γ-secreting HIV-specific T cells during successful antiretroviral therapy.
HIV Med
; 14(4): 241-6, 2013 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-22934786
12.
HLA-Bw4 identifies a population of HIV-infected patients with an increased capacity to control viral replication after structured treatment interruption.
HIV Med
; 13(10): 589-95, 2012 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-22500819
13.
Efficacy, tolerability and risk factors for virological failure of darunavir-based therapy for treatment-experienced HIV-infected patients: the Swiss HIV Cohort Study.
HIV Med
; 12(5): 299-307, 2011 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-20955357
14.
Pulmonary toxoplasmosis, a rare but severe manifestation of a common opportunistic infection in late HIV presenters: report of two cases.
Infection
; 38(2): 141-4, 2010 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-20352286
15.
Hemophagocytic syndrome caused by primary herpes simplex virus 1 infection: report of a first case.
Infection
; 38(5): 423-6, 2010 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-20602145
16.
Prevalence of etravirine mutations and impact on response to treatment in routine clinical care: the Swiss HIV Cohort Study (SHCS).
HIV Med
; 10(10): 647-56, 2009 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-19732174
17.
Recovery of replication-competent HIV despite prolonged suppression of plasma viremia.
Science
; 278(5341): 1291-5, 1997 Nov 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-9360926
18.
Predictive value of known and novel alleles of CYP2B6 for efavirenz plasma concentrations in HIV-infected individuals.
Clin Pharmacol Ther
; 81(4): 557-66, 2007 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-17235330
19.
Contribution of APOBEC3G/F activity to the development of low-abundance drug-resistant human immunodeficiency virus type 1 variants.
Clin Microbiol Infect
; 22(2): 191-200, 2016 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-26482266
20.
Efavirenz intoxication due to slow hepatic metabolism.
Clin Infect Dis
; 40(3): e22-3, 2005 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-15668854